Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Hematoxylin and Lactocrine Signals in Pig Uterus
2026-11-17
A paired-littermate study connected naturally low neonatal immunoglobulin transfer with altered uterine gland development, reduced FOXA2 representation, and coordinated developmental and immune transcriptional changes at postnatal day 14. Hematoxylin supported the tissue-visualization layer, while the biological conclusions concern lactocrine signaling rather than a causal effect of the stain.
Quantifying Organelle Proximity with Super-Resolution
2026-11-17
A methods-focused study evaluates whether Airyscan and structured illumination microscopy, combined with feature-based pixel classification, can improve the structural segmentation and morphology-based analysis of organelle proximity in living cells. The evidence supports better delineation than confocal imaging and more continuous masks than simple thresholding, while showing that mask overlap remains an indirect indicator of contact-site organization rather than proof of molecular tethering.
ACE2–MasR–Sirt1 Signaling in Septic Heart Injury
2026-11-16
A mouse study linked ACE2 activation with changes in septic cardiac dysfunction and a MasR–Sirt1 mitochondrial-biogenesis program, while highlighting the limits of pharmacological and model-based inference.
ACE2–MasR–Sirt1 Signaling in Septic Heart Injury
2026-11-16
A mouse study examined whether pharmacological ACE2 modulation changes sepsis-associated cardiac injury and whether the response is linked to MasR–Sirt1-regulated mitochondrial biogenesis. The findings support a mechanistic association in the experimental model, while leaving translation to human sepsis and target-specific causality unresolved.
ACE2 Activation in Septic Heart Injury
2026-11-15
A mouse study examined whether pharmacological ACE2 activation changes sepsis-induced cardiomyopathy and whether the response is linked to MasR-Sirt1-regulated mitochondrial biogenesis. The findings support a model-specific mechanistic association, while leaving target specificity and clinical translation unresolved.
ACE2, Mitochondria, and Septic Heart Injury
2026-11-14
A mouse study examined whether ACE2 activity influences sepsis-induced cardiomyopathy and linked the reported cardiac effects to MasR-Sirt1-associated mitochondrial biogenesis. The findings support a preclinical pathway hypothesis, not a clinical treatment conclusion.
Deuterium-Labeled Degarelix: What the Synthesis Shows
2026-11-13
A paper-centred interpretation of a synthetic chemistry study that used deuterium incorporation to create a mass-distinct degarelix acetate reference material. The evidence supports chemical feasibility and analytical characterization, while leaving biological and clinical questions outside the study’s scope.
ACE2–MasR–Sirt1 Signaling in Septic Cardiomyopathy
2026-11-13
A paper-centred interpretation of a mouse study examining whether pharmacological ACE2 perturbation changes sepsis-associated cardiac injury and whether the response is linked to MasR–Sirt1-regulated mitochondrial biogenesis.
ACE2–MasR Signaling in Septic Cardiomyopathy
2026-11-12
A mouse study examined whether pharmacological ACE2 activation or inhibition alters sepsis-associated cardiac injury. Its findings connect ACE2 activity with MasR-Sirt1-linked mitochondrial biogenesis, while leaving the pathway’s causal and translational significance open.
Reciprocal Glial Signaling After Spinal Injury
2026-11-12
A mouse study identifies a reciprocal signaling circuit in which astrocyte-derived CSF1 supports lesion-associated microglia, while microglial IFN-β supports astrocyte survival and coordinated tissue repair. Genetic disruption and rescue experiments indicate that these pathways cooperate but are not interchangeable.
ACE2–MasR–Sirt1 Signaling in Septic Cardiomyopathy
2026-11-11
A mouse study investigated whether ACE2 signaling influences sepsis-induced cardiac injury and whether MasR–Sirt1-associated mitochondrial biogenesis explains the observed effects. The findings support a preclinical mechanistic model, while remaining limited by the animal model and pharmacological nature of the perturbations.
ACE2, Mitochondria, and Septic Cardiomyopathy
2026-11-11
A mouse study examined whether pharmacological ACE2 activation changes sepsis-induced cardiomyopathy and whether the effect is linked to MasR-Sirt1-mediated mitochondrial biogenesis. The findings support a mechanistic association in the experimental model, while leaving questions about direct causality and translation to human sepsis.
ACE2, Mitochondria, and Septic Cardiomyopathy
2026-11-10
An in vivo mouse study examined whether pharmacological ACE2 modulation changes sepsis-induced cardiomyopathy and whether the response is associated with MasR-Sirt1-mediated mitochondrial biogenesis. The findings support a mechanistic association between ACE2 activity, cardiac stress responses, and mitochondrial regulation, while remaining limited by the pharmacological and mouse-model design.
ACE2–MasR Signaling in Septic Cardiomyopathy
2026-11-10
A mouse study investigated whether pharmacological ACE2 modulation changes sepsis-associated cardiac injury and whether the response is linked to MasR-Sirt1-mediated mitochondrial biogenesis. The findings support a model in which ACE2 signaling is connected to cardiac function, inflammation, oxidative stress, apoptosis, and mitochondrial regulation, while remaining limited to an experimental sepsis model.
ACE2–MasR–Sirt1 in Septic Cardiomyopathy
2026-11-09
A mouse study examined whether ACE2 modulation changes sepsis-associated cardiac injury and whether MasR–Sirt1-linked mitochondrial biogenesis provides a mechanistic explanation. The findings support a pathway-associated interpretation while remaining limited to an experimental model.